ERBB2 and breast carcinoma: The HER2-positive BT-474 breast cancer cell line overexpressing SHP2 [19] and the MCF-10A cells and MEFs ectopically overexpressing HER2 and EGFR were used as positive controls, while parental MCF-10A cells and MEFs as well as HMLE cells were used as negative controls for overexpression.